Literature DB >> 23659180

Selected ion flow tube mass spectrometry analysis of exhaled breath for volatile organic compound profiling of esophago-gastric cancer.

Sacheen Kumar1, Juzheng Huang, Nima Abbassi-Ghadi, Patrik Španěl, David Smith, George B Hanna.   

Abstract

Exhaled breath analysis of volatile organic compounds (VOCs) has great potential in terms of disease diagnosis and measuring physiological response to treatment. In this study, selected ion flow tube mass spectrometry (SIFT-MS) has been applied for the quantification of VOCs in the exhaled breath from 3 groups of patients, viz., those with esophago-gastric cancer, noncancer diseases of the upper gastro-intestinal tract, and a healthy upper gastrointestinal tract cohort. A total of 17 VOCs have been investigated in this study. The concentrations of 4 VOCs, hexanoic acid, phenol, methyl phenol, and ethyl phenol, were found to be significantly different between cancer and positive control groups using the Mann-Whitney U test. Receiver operating characteristics (ROC) analysis was applied for a combination of 4 VOCs (hexanoic acid, phenol, methyl phenol, and ethyl phenol) to discriminate the esophago-gastric cancer cohort from positive controls. The integrated area under the ROC curve (AUC) is 0.91. The results highlight the potential of VOC profiling as a noninvasive test to identify those with esophago-gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23659180     DOI: 10.1021/ac4010309

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  32 in total

1.  Metabolomic analysis of breath volatile organic compounds reveals unique breathprints in children with inflammatory bowel disease: a pilot study.

Authors:  N Patel; N Alkhouri; K Eng; F Cikach; L Mahajan; C Yan; D Grove; E S Rome; R Lopez; R A Dweik
Journal:  Aliment Pharmacol Ther       Date:  2014-07-16       Impact factor: 8.171

Review 2.  Point-of-care testing in the diagnosis of gastrointestinal cancers: current technology and future directions.

Authors:  Jeremy R Huddy; Melody Z Ni; Sheraz R Markar; George B Hanna
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

3.  Validation Study of Selected Ion Flow Tube-Mass Spectrometry (SIFT-MS) in Heritage Science: Characterization of Natural and Synthetic Paint Varnishes by Portable Mass Spectrometry.

Authors:  Jacopo La Nasa; Francesca Modugno; Maria Perla Colombini; Ilaria Degano
Journal:  J Am Soc Mass Spectrom       Date:  2019-09-05       Impact factor: 3.109

4.  Distinguish oral-source VOCs and control their potential impact on breath biomarkers.

Authors:  Dianlong Ge; Jijuan Zhou; Yajing Chu; Yan Lu; Xue Zou; Lei Xia; Yawei Liu; Chaoqun Huang; Chengyin Shen; Liwei Zhang; Huanzhong Wang; Yannan Chu
Journal:  Anal Bioanal Chem       Date:  2022-01-04       Impact factor: 4.142

5.  Analysis of volatile organic compounds from deep airway in the lung through intubation sampling.

Authors:  Wei Xu; Jin Zhang; Houwen Ding; Yueting Ding; Xue Zou; Min Yang; Qiang Zhou; Zhou Liu; Ling Zheng; Heping Zuo; Dianlong Ge; Qiangling Zhang; Chaoqun Huang; Chengyin Shen; Yannan Chu
Journal:  Anal Bioanal Chem       Date:  2022-08-26       Impact factor: 4.478

Review 6.  Translational metabolomics in cancer research.

Authors:  Nathaniel W Snyder; Clementina Mesaros; Ian A Blair
Journal:  Biomark Med       Date:  2015-09-01       Impact factor: 2.851

7.  Accuracy and Methodologic Challenges of Volatile Organic Compound-Based Exhaled Breath Tests for Cancer Diagnosis: A Systematic Review and Meta-analysis.

Authors:  George B Hanna; Piers R Boshier; Sheraz R Markar; Andrea Romano
Journal:  JAMA Oncol       Date:  2019-01-10       Impact factor: 31.777

8.  Selected ion flow tube mass spectrometry for targeted analysis of volatile organic compounds in human breath.

Authors:  Ilaria Belluomo; Piers R Boshier; Antonis Myridakis; Bhamini Vadhwana; Sheraz R Markar; Patrik Spanel; George B Hanna
Journal:  Nat Protoc       Date:  2021-06-04       Impact factor: 13.491

9.  Research protocol for a diagnostic study of non-invasive exhaled breath analysis for the prediction of oesophago-gastric cancer.

Authors:  Sheraz R Markar; Jesper Lagergren; George B Hanna
Journal:  BMJ Open       Date:  2016-01-06       Impact factor: 2.692

10.  Sequential simulation (SqS) of clinical pathways: a tool for public and patient engagement in point-of-care diagnostics.

Authors:  Jeremy R Huddy; Sharon-Marie Weldon; Shvaita Ralhan; Tim Painter; George B Hanna; Roger Kneebone; Fernando Bello
Journal:  BMJ Open       Date:  2016-09-13       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.